Clinico-radiological Spectrum and Predictors of Disease Severity in Neurological Wilson Disease: A Single Center Observational Study.
Objective: To determine the Clinical and radiological spectrum of neurological Wilson’s disease (WD) and predictors of disease severity. Background: Wilson’s Disease (WD) is autosomal recessive,…Anosognosia for hardware-related complications in deep brain stimulation
Objective: In this series, we report two rare cases of selective unawareness to hardware-related complications in deep brain stimulation (DBS). Background: DBS has shown good…Neurophenomenological Aspects of Monocular Visual Hallucinations in Charles Bonnet Syndrome in a patient with Parkinson’s Disease
Objective: This inquiry aims to augment understanding of Charles Bonnet Syndrome (CBS) by scrutinizing both monocular and bilateral visual hallucinations. It focuses on an atypical…Serotonin Transporter Dynamics in Multiple System Atrophy: Insights from 123I-FP-CIT SPECT Imaging
Objective: We aimed to visualize a serotonin transporter (SERT) based on 123I-FP-CIT SPECT, and assessing the binding distribution characteristics of the brainstems between patients with…Explore cellular heterogeneities of orbitofrontal cortex in multiple system atrophy using spatial transcriptomics
Objective: To explore the spatial organization and cellular complexity of the orbitofrontal cortex (OFC) in multiple system atrophy (MSA) via spatial transcriptomic (SRT). Background: The…Legmain/Asparaginyl endopeptidase-resistant tau fibril fold produces corticobasal degeneration-specific C-terminal tau fragment
Objective: This study monitored the formation of CBD (corticobasal degeneration)-type fibrils that exhibit astrocytic plaques, a characteristic CBD pathology, using Legumain-cleavage site-specific antibodies and CBD-specific…Combined application of alpha-synuclein and 4-repeat tau seed amplification assays for the differential diagnosis of parkinsonian disorders
Objective: To assess alpha-synuclein (a-syn) and 4-repeat tau (4RT) seed amplification assay (SAA) positivity rates in biosamples from people with Parkinson’s disease (PD) and Progressive…Hydrocephalic Progressive Supranuclear Palsy: An Underrecognized Entity
Objective: We describe a case of NPH-like presentation of PSP, review literature surrounding this entity, and discuss key diagnostic considerations and implications. Background: Despite advances…Path To Prevention (P2P) Therapeutics Platform Trial in Stage 2B Neuronal Alpha-Synuclein Disease: Study Update
Objective: To describe the study design and timeline of the first interventional study in Neuronal α-Synuclein Disease (NSD). Background: P2P is a platform, Phase 2…New α-Synuclein Strain Biomarker in Parkinson’s Disease and Related Dementia
Objective: Biomarker development for Parkinson’s disease and related dementia. Background: α-Synuclein (α-syn) strains can serve as discriminators of Parkinson's disease (PD) from other α-synucleinopathies. However,…
- « Previous Page
- 1
- …
- 100
- 101
- 102
- 103
- 104
- …
- 181
- Next Page »